Michael R. Mattern
Impact in
- Toxicology top 0.1%
- Bioactive Compounds and Antitumor Agents
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
Papers in
-
- Cancer therapeutics and mechanisms 32
- DNA Repair Mechanisms 29
- Ubiquitin and proteasome pathways 28
- DNA and Nucleic Acid Chemistry 15
- Protein Degradation and Inhibitors 10
- Oncology 35
- Peptidase Inhibition and Analysis 12
- Cancer-related Molecular Pathways 10
- Co-authors
- Randall K. Johnson (17 shared papers)Christopher K. Mirabelli (8 shared papers)Tauseef R. Butt (10 shared papers)F H Drake (4 shared papers)Richard Woessner (5 shared papers)Stanley T. Crooke (6 shared papers)Glenn A. Hofmann (11 shared papers)Benjamin Nicholson (13 shared papers)
- Journals
- Journal of Natural Products (9 papers)Biochemistry (5 papers)Experimental Cell Research (3 papers)Molecular Cancer Therapeutics (3 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Michael R. Mattern
106 papers receiving 6.7k citations
Peers
Comparison fields: 5 of 125
- Toxicology 631
- Oncology 2.5k
- Molecular Biology 5.6k
- Cancer Research 591
- Biotechnology 253
Countries citing papers authored by Michael R. Mattern
This map shows the geographic impact of Michael R. Mattern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Mattern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Mattern more than expected).
Fields of papers citing papers by Michael R. Mattern
This network shows the impact of papers produced by Michael R. Mattern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Mattern. The network helps show where Michael R. Mattern may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael R. Mattern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 435 | |
| 2 | Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. | 1991 | 411 |
| 3 | 2005 | 387 | |
| 4 | 1989 | 366 | |
| 5 | 1989 | 363 | |
| 6 | 1999 | 345 | |
| 7 | 2000 | 248 | |
| 8 | In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride. | 1986 | 194 |
| 9 | 2012 | 155 | |
| 10 | 2002 | 147 | |
| 11 | In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. | 1989 | 147 |
| 12 | 1989 | 142 | |
| 13 | 1980 | 139 | |
| 14 | Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). | 1991 | 135 |
| 15 | 1986 | 133 | |
| 16 | Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. | 1987 | 127 |
| 17 | Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas. | 1984 | 117 |
| 18 | 2008 | 115 | |
| 19 | 1990 | 106 | |
| 20 | 1979 | 104 |
About Michael R. Mattern
Michael R. Mattern is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Cancer Research and Biotechnology, having authored 107 papers that have together received 7.0k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (32 papers), DNA Repair Mechanisms (29 papers), Ubiquitin and proteasome pathways (28 papers), DNA and Nucleic Acid Chemistry (15 papers), Peptidase Inhibition and Analysis (12 papers), Protein Degradation and Inhibitors (10 papers), Cancer-related Molecular Pathways (10 papers) and Synthesis and Biological Evaluation (8 papers). The work is most often cited by research in Toxicology (631 citations), Oncology (2.5k citations), Molecular Biology (5.6k citations), Cancer Research (591 citations) and Biotechnology (253 citations). Michael R. Mattern has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Randall K. Johnson, Christopher K. Mirabelli, Tauseef R. Butt, F H Drake, Richard Woessner, Stanley T. Crooke, Glenn A. Hofmann, Benjamin Nicholson, Dominic A. Scudiero and G A Hofmann. Their work appears in journals such as Journal of Natural Products, Biochemistry, Experimental Cell Research, Molecular Cancer Therapeutics and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.